Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space…
Metagenomi, Inc. (MGX): A Game Changer in Gene Editing and Therapeutic…
ADC Therapeutics SA Soars on Positive Preliminary Results from ZYNLONTA® Clinical…
Janux Therapeutics Reports Breakthrough in Prostate Cancer Treatment with JANX007
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for…
Finance
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from…
Monte Rosa Therapeutics Soars on Novartis Deal: A Molecular Glue Revolution
Betforward: A Gateway to Sports Betting and Online Gaming
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Citius Pharmaceuticals Inc. (NASDAQ:CTXR)
Tag: Citius Pharmaceuticals Inc. (NASDAQ:CTXR)
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Receives Study May Proceed Letter from...
Kate Hudson
-
March 1, 2022
0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Finalizes Patient Enrolment In Pivotal Phase...
Gavins Felicity
-
December 29, 2021
0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Completes Patients Recruitment In Phase 3...
Kate Hudson
-
December 13, 2021
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Reports Study Results Showing Effectiveness of Mino-Lok...
Ash K
-
December 21, 2020
0
Citius Pharmaceuticals (NASDAQ:CTXR) And Novellus Therapeutics Enter Exclusive Global Licensing Agreement...
Gavins Felicity
-
October 15, 2020
0
1
2
Page 1 of 2
Recent Post
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space...
Kate Hudson
-
December 9, 2024
0
In the bustling arena of biopharmaceutical advancements, Kodiak Sciences Inc. (NASDAQ:KOD) is emerging as a key player, particularly in the field of...
Metagenomi, Inc. (MGX): A Game Changer in Gene Editing and Therapeutic...
December 9, 2024
ADC Therapeutics SA Soars on Positive Preliminary Results from ZYNLONTA® Clinical...
December 6, 2024
Janux Therapeutics Reports Breakthrough in Prostate Cancer Treatment with JANX007
December 3, 2024
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for...
December 3, 2024
romabet
mahbet
پین باهیس
bettingmagazine.org
بت کارت
یاس بت
yekbet
megapari
onjabet
alvinbet
betboro
betfa
بت فوروارد
1xbet
1win
betwinner
4shart.com
1xbetgiris.cam
وان کیک بت
وین بت
ریتزوبت
1xbet-ir.com.co
وان ایکس بت
بت فوروارد